The global severe hypertriglyceridemia (SHTG) treatment market, which achieved a valuation of USD 615 million in 2022, is projected to experience rapid growth, reaching approximately USD 2675.37 Million by 2033. This expansion represents a strong CAGR of 14.3% over the forecast period from 2023 to 2033, driven by a growing incidence of SHTG cases and …